Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Abstract 5273: Systematic functional screening, miRNA and target expression analyses reveal miR-19, -124, -583, -129 and -876 as key nodes in prostate cancer proliferation networks.

Päivi Östling, Suvi-Katri Leivonen, Pekka Kohonen, Anna Aakula, Petteri Hintsanen, Tero Aittokallio, Merja Perälä, Olli Kallioniemi

Cancer Res (2013) 73 (8_Supplement): 5273.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5273

Published: 15 April 2013

View article

Journal Articles

Abstract 4170: MicroRNA-135b influences androgen and estrogen receptor protein levels and regulates proliferation of hormone-receptor positive prostate and breast cancer cells.

Anna Aakula, Suvi-Katri Leivonen, Pekka Kohonen, Petteri Hintsanen, Tero Aittokallio, Yvonne Ceder, Anne-Lise Børresen-Dale, Merja Perälä, Päivi Östling, Olli Kallioniemi

Cancer Res (2013) 73 (8_Supplement): 4170.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4170

Published: 15 April 2013

View article

Journal Articles

Abstract 3847: High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells .

Vesa J. Hongisto, Sandra Nyberg, Vidal Fey, John-Patrick Mpindi, Olli Kallioniemi, Merja Perälä

Cancer Res (2013) 73 (8_Supplement): 3847.

DOI: https://doi.org/10.1158/1538-7445.AM2013-3847

Published: 15 April 2013

View article

Journal Articles

Abstract 2107: Identification of alternative compounds by drug screening of HER2 positive breast cancer cell lines.

Sandra Nyberg, Vesa Hongisto, Dagim Shiferaw Tadele, Henrik Edgren, Suvi-Katri Leivonen, Olli Kallioniemi, Gunhild Mari Mælandsmo, Merja Perälä, Anne-Lise Børresen-Dale, Kristine Kleivi Sahlberg

Cancer Res (2013) 73 (8_Supplement): 2107.

DOI: https://doi.org/10.1158/1538-7445.AM2013-2107

Published: 15 April 2013

View article

Journal Articles

Abstract 3800: HES6 gene is a strong glioma biomarker and a key transcriptional regulator needed for cancer cell growth

Saija M. Haapa-Paananen, Santeri Kiviluoto, Marika Waltari, Marjut Puputti, John-Patrick Mpindi, Pekka Kohonen, Olli Tynninen, Hannu Haapasalo, Heikki Joensuu, Merja Perälä, Olli Kallioniemi

Cancer Res (2011) 71 (8_Supplement): 3800.

DOI: https://doi.org/10.1158/1538-7445.AM2011-3800

Published: 15 April 2011

View article

Journal Articles

Abstract 3977: Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells

Päivi Östling, Suvi-Katri Leivonen, Anna Aakula, Pekka Kohonen, Rami Mäkelä, Zandra Hagman, Anders Edsjö, Sara Kangaspeska, Henrik Edgren, Daniel Nicorici, Anders Bjartell, Yvonne Ceder, Merja Perälä, Olli Kallioniemi

Cancer Res (2011) 71 (8_Supplement): 3977.

DOI: https://doi.org/10.1158/1538-7445.AM2011-3977

Published: 15 April 2011

View article

Journal Articles

Abstract 4836: In vitro drug sensitivity testing along with full genome and transcriptome sequencing and phosphoproteomics: Comprehensive “next-generation” molecular oncology portrait of a sarcoma for facilitating treatment decisions

Cancer Res (2011) 71 (8_Supplement): 4836.

DOI: https://doi.org/10.1158/1538-7445.AM2011-4836

Published: 15 April 2011

View article

Journal Articles

Abstract 845: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

Sirkku Pollari, Rami Käkönen, Khalid S. Mohammad, Jukka P. Rissanen, Jussi Halleen, Anni Wärri, Liisa Nissinen, Marjo Pihlavisto, Anne Marjamäki, Merja Perälä, Theresa Guise, Olli Kallioniemi, Sanna-Maria Käkönen

Cancer Res (2011) 71 (8_Supplement): 845.

DOI: https://doi.org/10.1158/1538-7445.AM2011-845

Published: 15 April 2011

View article

Journal Articles

Abstract 4708: Hes6 as a glioma biomarker with functional significance for cancer growth

Saija M. Haapa-Paananen, Marika Waltari, Marjut Puputti, Santeri Kiviluoto, John-Patrick Mpindi, Pekka Kohonen, Olli Tynninen, Hannu Haapasalo, Heikki Joensuu, Merja Perälä, Olli Kallioniemi

Cancer Res (2010) 70 (8_Supplement): 4708.

DOI: https://doi.org/10.1158/1538-7445.AM10-4708

Published: 15 April 2010

View article

Journal Articles

Abstract 1953: Functional identification of microRNA targets by integrated proteomics and microarray profiling: miR-193b in breast cancer

Suvi-Katri Leivonen, Anne Rokka, Päivi Östling, Pekka Kohonen, Garry Corthals, Merja Perälä, Olli Kallioniemi

Cancer Res (2010) 70 (8_Supplement): 1953.

DOI: https://doi.org/10.1158/1538-7445.AM10-1953

Published: 15 April 2010

View article

Journal Articles

A novel array-based “DNA/RNA outlier analysis” distinguishes key pathogenetic genes and novel therapeutic targets in breast cancer.

Henrik Edgren, Maija Wolf, Rolf Skotheim, Sami Kilpinen, Reija Autio, Aslaug Muggerud, Therese Sörlie, Kristiina Iljin, Outi Monni, Saija Haapa-Paananen, Merja Perälä, Olli Kallioniemi

Cancer Res (2006) 66 (8_Supplement): 1339.

Published: 15 April 2006

View article

Journal Articles

RNA interference profiles, gene expression, and copy number changes in bone metastatic breast cancer cells: an integrated molecular and functional screening

Sirkku Pollari, Merja Perälä, Saija Haapa-Paananen, Niko Sahlberg, Kirsi Ojala, Pekka Tiikkainen, Maija Wolf, Henrik Edgren, Jukka Rissanen, Jussi Halleen, Sanna-Maria Käkönen, Olli-P. Kallioniemi

Cancer Res (2006) 66 (8_Supplement): 978.

Published: 15 April 2006

View article

NARROW

Abstract 5273: Systematic functional screening, miRNA and target expression analyses reveal miR-19, -124, -583, -129 and -876 as key nodes in prostate cancer proliferation networks.

Abstract 4170: MicroRNA-135b influences androgen and estrogen receptor protein levels and regulates proliferation of hormone-receptor positive prostate and breast cancer cells.

Abstract 3847: High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells .

Abstract 2107: Identification of alternative compounds by drug screening of HER2 positive breast cancer cell lines.

Abstract 3800: HES6 gene is a strong glioma biomarker and a key transcriptional regulator needed for cancer cell growth

Abstract 3977: Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells

Abstract 4836: In vitro drug sensitivity testing along with full genome and transcriptome sequencing and phosphoproteomics: Comprehensive “next-generation” molecular oncology portrait of a sarcoma for facilitating treatment decisions

Abstract 845: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

Abstract 4708: Hes6 as a glioma biomarker with functional significance for cancer growth

Abstract 1953: Functional identification of microRNA targets by integrated proteomics and microarray profiling: miR-193b in breast cancer

A novel array-based “DNA/RNA outlier analysis” distinguishes key pathogenetic genes and novel therapeutic targets in breast cancer.

RNA interference profiles, gene expression, and copy number changes in bone metastatic breast cancer cells: an integrated molecular and functional screening

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only